REPRODIVAC - Next-generation vaccines and diagnostics to prevent livestock reproductive diseases of worldwide impact

13th International Veterinary Immunology Symposium (IVIS)

IVIS Symposiium

The 13th International Veterinary Immunology Symposium (IVIS) will be held in South Africa at the Kruger National Park on the 17-21 November 2023. 

Every three years IVIS brings together immunologists from the industry, universities, health services and independent research organizations from across the globe to share most exciting results and insights in the field of veterinary science and immunology, including biological mechanisms underlying host-pathogen interactions and specificities, vaccine and therapeutic strategies, innate and protective immunity, disease diagnosis and control, reagent and methodological developments. 

The Kruger Park and surrounding rural areas are emblematic of both the opportunities and threats that co-exist at the interface of human societies, their domestic animals, free-living wildlife, and the environments that they inhabit. In a context of global change, sustainably improved livestock systems and disease control are essential for not only the commercial livestock trade, but also for subsistence farming, food safety and security, human wellbeing, and the biodiversity conservation of ecologically and economically important ecosystems. In this spirit, the IVIS 2023 will address the challenging research issues raised for veterinary science in a One World – One Health perspective.

 IVIS – Symposium 2023

Event Information

Event Date 11-17-2023
Event End Date 11-21-2023
Location Kruger National Park South Africa

REPRODIVAC has received funding from the European Union’s Horizon Europe research and innovation programme under Grant Agreement No. 101060813. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or other granting authorities. Neither the European Union nor the other granting authorities can be held responsible for them.

REPRODIVAC has received funding from the European Union’s Horizon Europe research and innovation programme under Grant Agreement No. 101060813. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or other granting authorities. Neither the European Union nor the other granting authorities can be held responsible for them.

Feedback